Alcohol and Atrial Fibrillation: More Reasons for Moderate Consumption

Reducing alcohol consumption should be included in the “package” of secondary prevention recommendations, not only for its impact on arteries, but also because it reduces atrial fibrillation (AF).

Consumo de alcohol y fibrilación auricular

Alcohol abstinence might improve arrhythmia symptoms and reduce the chances of recurrence in patients who have already had an episode of AF.

Regular alcohol consumers who were randomized to alcohol abstinence for 6 months experienced less than half of the hospitalizations due to atrial fibrillation compared with patients who continued their usual alcohol consumption.

Alcohol can function as a trigger for AF and it has been studied specifically in works that associated regular alcohol consumption with left atrial enlargement, impaired left atrial contraction, and adverse electrical remodeling.


Read also: Is Alcohol Good, Bad, or Neutral for Cardiovascular Health?


Whether abstinence from alcohol could reduce arrhythmia in patients with a history of AF was still unclear. This is precisely the contribution made by this work, recently published in the prestigious New England Journal of Medicine.

This Alcohol-FA study randomized 140 patients to alcohol abstinence or consumption in the amount they already consumed regularly. The group randomized to abstinence accomplished an 87.2% reduction in their total alcohol intake (from 17 drinks per week to just 2 drinks). The group with continued consumption also slightly reduced the amount (about 20%, from 16 to 13 drinks per week).

Atrial fibrillation recurrence (one of the primary endpoints) was significantly lower in the abstinence group vs. the control group (53% vs. 73%). Additionally, the period before recurrence was longer.


Read also: Progress of patients with hypertrophic cardiomyopathy treated with alcohol septal ablation.


On top of the benefits in terms of arrhythmia, alcohol abstinence was associated with obesity reduction and less symptoms due to arrhythmia.

There are even data suggesting that a 6-month abstinence could reduce both systolic and diastolic pressure.

On the other hand, alcohol does not seem to be the true culprit behind arrhythmia. Abstinence may reduce recurrence and symptoms for a while, but it is not a definitive solution.


Read also: FFR in the Time of ISCHEMIA.


There is also another undeniable truth: complete abstinence is very hard to achieve. This study was originally planned with a 12-month follow-up, but that had to be reduced to only 6 months because patients refused to enroll if they had to spend a year without drinking. About 70% of patients who were invited to take part in this study refused randomization after considering that they would not be able to maintain their abstinence.

All of this applies to regular alcohol consumption: there is no evidence suggesting that occasional consumption may prevent cardiovascular events such as an episode of atrial fibrillation.

Original Title: Alcohol abstinence in drinkers with atrial fibrillation.

Reference: Voskoboinik A et al. N Engl J Med. 2020;382:20-28.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

SMART-CHOICE 3 | Efficacy and Safety of Clopidogrel vs Aspirin Monotherapy in High Risk Patients after Percutaneous Coronary Intervention

Courtesy of Dr. Juan Manuel Pérez. After post percutaneous coronary intervention (PCI) standard duration dual antiplatelet therapy (DAPT), the optimal long term monotherapy strategy is...

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Pretreatment with DAPT in Acute Coronary Syndrome: An Ongoing Debate?

In acute coronary syndrome (ACS) dual antiplatelet therapy (DAPT) has become a fundamental pillar after percutaneous coronary intervention (PCI), preventing stent thrombosis and acute...

Measuring Post-TAVI Gradients and Their Implications: Are Invasive and Echocardiographic Assessments Comparable?

Transcatheter aortic valve implantation (TAVI) is considered the treatment of choice for a significant proportion of patients with symptomatic aortic stenosis. Outcomes have improved...

Another Blow for Intra-Aortic Balloon Pumo Counterpulsation? Randomized Study on Its Use in Chronic Heart Failure Progressing to Cardiogenic Shock

Cardiogenic shock (CS) remains a condition with extremely high mortality (around 50%). While most therapies for this pathology have been studied in CS secondary...